ICON plc Schedules Second Quarter 2024 Earnings Conference Call
ICON plc (NASDAQ: ICLR), a global leader in healthcare intelligence and clinical research, has announced the release of its second quarter 2024 financial results. The results will be disclosed after market hours on July 24, 2024. A conference call and webcast to discuss these results are scheduled for July 25, 2024, at 8:00am ET. Updates and links to the live webcast will be available on the Investor section of ICON's website under 'Events.' A replay of the webcast will be accessible approximately an hour after the call concludes.
- Announcement of Q2 2024 financial results release date provides transparency.
- Scheduled conference call and webcast demonstrate open communication with investors.
- None.
Any changes to these events and links to the live webcasts (where available) will be posted on the Investor section of our website under “Events”. A webcast replay of the conference call will be available approximately one hour following the conclusion of the call.
About ICON plc
ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in
This press release contains forward-looking statements, including statements about our financial guidance. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.
ICON/ICLR-G
View source version on businesswire.com: https://www.businesswire.com/news/home/20240701863048/en/
Kate Haven
Vice President Investor Relations
+1888 381 7923
Source: ICON plc
FAQ
When will ICON plc release its Q2 2024 financial results?
When is ICON plc's earnings conference call for Q2 2024?
How can I access the Q2 2024 earnings conference call for ICON plc?